Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SERPINE1 | P05121 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 7/20 | 0.49 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.49 |
| ▸ | CYP1A1 | P04798 | 4/20 | 0.48 |
| ▸ | FADS1 | O60427 | 1/20 | 0.47 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.46 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.46 |
| ▸ | IDO1 | P14902 | 1/20 | 0.45 |
| ▸ | NUDT1 | P36639 | 2/20 | 0.45 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.45 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.45 |
| ▸ | DHFR | P00374 | 1/20 | 0.45 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25681090 | 0.98 | SERPINE1 (0.49) | SERPINE1CYP1A2CYP1B1CYP1A1FADS1 | |
| SCHEMBL25681075 | 0.96 | CYP1A2 (0.50) | SERPINE1CYP1A2CYP1B1CYP1A1FADS1 | |
| SCHEMBL23238902 | 0.96 | SERPINE1 (0.48) | SERPINE1CYP1A2CYP1B1CYP1A1FADS1 | |
| SCHEMBL26279852 | 0.91 | CYP1A2 (0.47) | SERPINE1CYP1A2CYP1B1CYP1A1FADS1 | |
| SCHEMBL27254523 | 0.90 | CYP1A2 (0.46) | SERPINE1CYP1A2CYP1B1CYP1A1FADS1 | |
| SCHEMBL25125118 | 0.88 | ALDH1A1 (0.46) | SERPINE1CYP1A2CYP1B1CYP1A1FADS1 | |
| SCHEMBL25681057 | 0.88 | NPC1 (0.48) | NUDT1ADORA2AADORA1CYP2A6DHFR | |
| SCHEMBL31229563 | 0.87 | CYP1A2 (0.43) | SERPINE1CYP1A2CYP1B1CYP1A1FADS1 | |
| SCHEMBL25681064 | 0.87 | CYP2A6 (0.50) | SERPINE1CYP1A2CYP1B1CYP1A1NUDT1 | |
| SCHEMBL31651446 | 0.86 | CYP1A2 (0.46) | SERPINE1CYP1A2CYP1B1CYP1A1FADS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230416201-A1 | ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND LIGHT-RECEIVING DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2023-12-28 | — | — | US | disclosed |
| CN-117209415-A | Organic compound, light-emitting device, and light-receiving device | 株式会社半导体能源研究所 | 2023-12-12 | — | — | CN | disclosed |
| US-11690292-B2 | Organic electronic element comprising a compound for organic electronic element and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-06-27 | — | — | US | disclosed |
| US-11690292-B2 | Organic electronic element comprising a compound for organic electronic element and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-06-27 | — | — | US | disclosed |
| US-20230129535-A1 | ORGANIC ELECTRONIC ELEMENT COMPRISING A COMPOUND FOR ORGANIC ELECTRONIC ELEMENT AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
| US-20230129535-A1 | ORGANIC ELECTRONIC ELEMENT COMPRISING A COMPOUND FOR ORGANIC ELECTRONIC ELEMENT AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
| US-5945422-A | ANTICANCER AGENTS; ATHEROSCLEROSIS; RESTENOSIS; PSORIASIS | WARNER-LAMBERT COMPANY (US) | 1999-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230416201-A1 | ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND LIGHT-RECEIVING DEVICE | CRY1, CRY2, NR2E3 | SERPINE1 3530/4885CYP1A2 168/4885CYP1B1 141/4885 |
| US-11690292-B2 | Organic electronic element comprising a compound for organic electronic element and an electronic device thereof | ESR1, EML4, ORAI2 | SERPINE1 3241/4885CYP1A2 354/4885CYP1B1 1090/4885 |
| US-20230129535-A1 | ORGANIC ELECTRONIC ELEMENT COMPRISING A COMPOUND FOR ORGANIC ELECTRONIC ELEMENT AND AN ELECTRONIC DEVICE THEREOF | ESR1, EML4, ORAI2 | SERPINE1 3241/4885CYP1A2 354/4885CYP1B1 1090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.